Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients.

Apar Kishor GantiNathanael R FillmoreJohn BihnJennifer LaMary T BrophyNhan V DoMichael Kelley

Published in: International journal of clinical oncology (2023)

The mortality of lung cancer patients from COVID-19 disease in the present cohort was less than previously reported in the literature. The identification of risk factors associated with severe or fatal outcomes informs management of patients with lung cancer who develop COVID-19 disease.

Keyphrases

coronavirus disease
risk factors
end stage renal disease
sars cov
newly diagnosed
ejection fraction
chronic kidney disease
systematic review
peritoneal dialysis
patient reported outcomes
adipose tissue
respiratory syndrome coronavirus
early onset
coronary artery disease
insulin resistance